A-21978 antibiotics and process for their production

Abstract

Antibiotic A-21978C complexes, in particular the A-21978C complex, comprising microbiologically active, related factors, C 0 , C 1 , C 2 , C 3 , C 4 , and C 5 . A-21978 complex and A-21978C complex are produced by submerged aerobic fermentation of Streptomyces roseosporus NRRL 11379. The individual A-21978C factors are separated and isolated by chromatography. The A-21978 and A-21978C complexes, the A-21978C factors, and pharmaceutically acceptable salts thereof are antibacterial agents and improve growth promotion in poultry.

We claim: 
     
       1. Antibiotic A-21978C factor C 0 , which has the following structural formula: ##STR4## wherein 3MG represents L-threo-3-methylglutamic acid, and R is a C 10  -alkanoyl moiety; and which has: (a) a molecular formula of approximately .[.C 72  H 100  N 16  O 27  :.]. .Iadd.C 72  H 101  N 17  O 26 .Iaddend. ;   (b) a molecular weight of approximately .Badd..[.1622.]..Baddend. .Iadd.1621.Iaddend.; and which, in sodium salt form, has these characteristics;   (c) an approximate elemental composition of 52.07% carbon, 5.95% hydrogen, 12.73% nitrogen, 25.84% oxygen and 3.4% sodium;   (d) an infrared absorption spectrum in KBr pellet as shown in FIG. 5 of the drawings;   (e) upon hydrolysis yields the following amino acids: aspartic acid, glycine, alanine, serine, threonine, tryptophan, ornithine, kynurenine, and 3-methylglutamic acid;   (f) is soluble in methanol, ethanol, propanol, butanol, dimethylformamide, dimethyl sulfoxide, dioxane, tetrahydrofuran, and water and in acidic and alkaline solutions, except at pH levels of below about pH 3.5; but is only slightly soluble or is insoluble in acetone, chloroform, diethyl ether, benzene, ethyl acetate, and hydrocarbon solvents;   (g) an R.sub.ƒ value of approximately 0.71 on reversed-phase silica-gel TLC in water:methanol:acetonitrile (45:15:40) which contains 0.2% pyridine and 0.2% acetic acid; and   (h) the following specific rotation: [α] D   25  +11.9° (c 0.7, H 2  O); or a cationic or acid addition salt of A-21978 factor C 0 .     
     
     
       2. A compound of claim 1 which is a pharmaceutically acceptable salt of A-21978C factor C 0 . 
     
     
       3. The compound of claim 1 which is A-21978C factor C 0  sodium salt. 
     
     
       4. Antibiotic A-21978C factor C 1 , which has the following structural formula: ##STR5## wherein 3MG represents L-threo-3-methylglutamic acid, and R is 8-methyldecanoyl; and which has: (a) an approximate molecular formula of .[.C 73  H 102  N 16  O 27  .]. .Iadd.C 73  H 103  N 17  O 26  .Iaddend.:   (b) an approximate molecular weight of .Badd..[.1636.]..Baddend. .Iadd.1635.Iaddend.; and which, in sodium salt form, has these characteristics:   (c) an approximate elemental composition of 52.47% carbon, 5.93% hydrogen, 13.38% nitrogen, 26.19% oxygen and 2.03% sodium:   (d) an infrared absorption spectrum in KBr pellet as shown in FIG. 2 of the drawings:   (e) upon hydrolysis yields the following amino acids: aspartic acid, glycine, alanine, serine, threonine, tryptophan, ornithine, kynurenine, and 3-methylglutamic acid;   (f) is soluble in methanol, ethanol, propanol, butanol, dimethylformamide, dimethyl sulfoxide, dioxane, tetrahydrofuran, and water and in acidic and alkaline solutions, except at pH levels of below about pH 3.5; but is only slightly soluble or is insoluble in acetone, chloroform, diethyl ether, benzene, ethyl acetate, and hydrocarbon solvents;   (g) an R.sub.ƒ value of approximately 0.64 on reversed-phase silica-gel TLC in a water:methanol:acetonitrile (45:15:40) which contains 0.2% pyridine and 0.2% acetic acid;   (h) the following specific rotation: [α] D   25  +16.9° (c 0.7, H 2  O);   (i) an ultraviolet absorption spectrum in neutral ethanol with maxima at 223 (E 1%   1  cm 307), 260 (E 1%   1  cm 62 ), 280 (E 1%   1  cm 39), 290 (E 1%   1  cm 35), and 360 nm (E 1%   1  cm 33); and   (j) two titratable groups in 66% aqueous dimethylformamide with pK.sub.α values of approximately 5.8 and 7.4; or a cationic or acid addition salt of A-21978C factor C 1 .   
     
     
       5. A compound of claim 4 which is a pharmaceutically acceptable salt of A-21978C factor C 1 . 
     
     
       6. The compound of claim 4 which is A-21978C factor C 1  sodium salt. 
     
     
       7. Antibiotic A-21978C factor C 2 , which has the following structural formula: ##STR6## wherein 3MG represents L-threo-3-methylglutamic acid, and R is 10-methylundecanoyl; and which has: (a) an approximate molecular formula of .[.C 74  H 104  N 16  O 27  .]. .Iadd.C 74  H 105  N 17  O 26  .Iaddend.;   (b) an approximate molecular weight of .Badd..[.1650.]..Baddend. .Iadd.1649.Iaddend.; and which, in sodium salt form, has these characteristics:   (c) an approximte elemental composition of 51.87% carbon, 6.05% hydrogen, 13.66% nitrogen, 25.86% oxygen and 2.56% sodium;   (d) an infrared absorption spectrum in KBr pellet as shown in FIG. 3 of the drawings;   (e) contains the following amino acids: aspartic acid, glycine, alanine, serine, threonine, tryptophan, ornithine, kynurenine, and 3-methylglutamic acid;   (f) is soluble in methanol, ethanol, propanol, butanol, dimethylformamide, dimethyl sulfoxide, dioxane, tetrahydrofuran, and water and in acidic and alkaline solutions, except at pH levels of below about pH 3.5; but is only slightly soluble or is insoluble in acetone, chloroform, diethyl ether, benzene, ethyl acetate, and hydrocarbon solvents;   (g) an R.sub.ƒ value of approximately 0.56 on reversed-phase silica-gel TLC in water:methanol:acetonitrile (45:15:40) which contains 0.2% pyridine and 0.2% acetic acid;   (h) the following specific rotation: [α] D   25  +18.6° (c 0.9, H 2  O);   (i) an ultraviolet absorption spectrum in neutral ethanol with the following absorption maxima: 223 (E 1%   1  cm 303), 260 (E 1%   1  cm 62), 280 (E 1%   1  cm 41), 290 (E 1%   1  cm 36 ), and 360 nm (E 1%   1  cm 33); and   (j) two titratable groups in 66% aqueous dimethylformamide with pK.sub.α values of approximately 5.9 and 7.6; or a cationic or acid addition salt of A-21978C factor C 2 .     
     
     
       8. A compound of claim 7 which is a pharmaceutically acceptable salt of A-21978C factor C 2 . 
     
     
       9. The compound of claim 7 which is A-21978C factor C 2  sodium salt. 
     
     
       10. Antibiotic A-21978C factor C 3 , which has the following structural formula: ##STR7## wherein 3MG represents L-threo-3-methylglutamic acid, and R is 10-methyldodecanoyl; and which has: (a) a molecular formula of approximately .[.C 75  H 106  N 16  O 27  .]..Iadd.C 75  H 107  N 17  O 26  .Iaddend.;   (b) a molecular weight of approximately .Badd..[.1664.]..Baddend. .Iadd.1663.Iaddend.; and which, in sodium salt form, has these characteristics:   (c) an approximate elemental composition of 54.18% carbon, 6.35% hydrogen, 13.34% nitrogen, 25.06% oxygen and 1.07% sodium;   (d) an infrared absorption spectrum in KBr pellet as shown in FIG. 4 of the drawings;   (e) upon hydrolysis yields the following amino acids: aspartic acid, glycine, alanine, serine, threonine, tryptophan, ornithine, kynurenine, and 3-methylglutamic acid;   (f) is soluble in methanol, ethanol, propanol, butanol, dimethylformamide, dimethyl sulfoxide, dioxane, tetrahydrofuran, and water and in acidic and alkaline solutions, except at pH levels of below about pH 3.5; but is only slightly soluble or is insoluble in acetone, chloroform, diethyl ether, benzene, ethyl acetate, and hydrocarbon solvents;   (g) an R.sub.ƒ value of approximately 0.47 on reversed-phase silica-gel TLC in water:methanol:acetonitrile (45:15:40) which contains 0.2% pyridine and 0.2% acetic acid;   (h) the following specific rotation: [α] D   25  +20.9° (c 0.4, H 2  O);   (i) an ultraviolet absorption spectrum in neutral ethanol with the following absorption maxima: 223 (E 1%   1  cm 300), 260 (E 1%   1  cm 63), 280 (E 1%   1  cm 42), 290 (E 1%   1  cm 38), and 360 nm (E 1%   1  cm 32);   (j) two titratable groups in 66% aqueous dimethylformamide with pK.sub.α values of approximately 5.74 and 7.56; or a cationic or acid addition salt of A-21978C factor C 3 .     
     
     
       11. A compound of claim 10 which is a pharmaceutically acceptable salt of A-21978C factor C 3 . 
     
     
       12. The compound of claim 10 which is A-21978C factor C 3  sodium salt. 
     
     
       13. Antibiotic A-21978C factor C 4 , which has the following structural formula: ##STR8## wherein 3MG represents L-threo-3-methylglutamic acid, and R is a C 12  -alkanoyl moiety; and which has: (a) an approximate molecular formula of .[.C 74  H 104  N 16  O 27  .]. .Iadd.C 74  H 105  N 17  O 26  .Iaddend.;   (b) an approximate molecular weight of .[.1650.]. .Iadd.1649 .Iaddend.; and which, in sodium salt form, has these characteristics:   (c) an approximtae elemental composition of 52.73% carbon, 5.99% hydrogen, 14.07% nitrogen, 25.81% oxygen and 3.4% sodium;   (d) an infrared absorption spectrum in KBr pellet as shown in FIG. 6 of the drawings;   (e) upon hydrolysis yields the following amino acids: aspartic acid, glycine, alanine, serine, threonine, tryptophan, ornithine, kynurenine, and 3-methylglutamic acid;   (f) is soluble in methanol, ethanol, propanol, butanol, dimethylformamide, dimethyl sulfoxide, dioxane, tetrahydrofuran, and water and in acidic and alkaline solutions, except at pH levels of below about pH 3.5; but is only slightly soluble or is insoluble in acetone, chloroform, diethyl ether, benzene, ethyl acetate, and hydrocarbon solvents;   (g) an R.sub.ƒ value of approximately 0.63 on reversed-phase silica-gel TLC in water:methanol:acetonitrile (45:15:40) which contains 0.2% pyridine and 0.2% acetic acid;   (h) the following specific rotation: [α] D   25  +14.8° (c 0.7, H 2  O); or a cationic or acid addition salt of A-21978C factor C 4 .     
     
     
       14. A compound of claim 13 which is a pharmaceutically acceptable salt of A-21978C factor C 4 . 
     
     
       15. The compound of claim 13 which is A-21978C factor C 4  sodium salt. 
     
     
       16. Antibiotic A-21978C factor C 5 , which has the following structural formula: ##STR9## wherein 3MG represents L-threo-3-methylglutamic acid, and R is a C 12  -alkanoyl moiety; and which has: (a) an approximate molecular formula of .[.C 74  H 104  N 16  O 27  .]. .Iadd.C 74  H 105  N 17  O 26  .Iaddend.;   (b) an approximate molecular weight of .Badd.1650.]..Baddend. .Iadd.1649.Iaddend.; and which, in sodium salt form, has these characteristics:   (c) an approximate elemental composition of 52.76% carbon, 6.71% hydrogen, 13.97% nitrogen, 25.60% oxygen and 1% sodium;   (d) an infrared absorption spectrum as shown in FIG. 7 of the drawings:   (e) upon hydrolysis yields the following amino acids: aspartic acid, glycine, alanine, serine, threonine, tryptophan, ornithine, kynurenine, and 3-methylglutamic acid;   (f) is soluble in methanol, ethanol, propanol, butanol, dimethylformamide, dimethyl sulfoxide, dioxane, tetrahydrofuran, and water and in acidic and alkaline solutions, except at pH levels of below about pH 3.5; but is only slightly soluble or is insoluble in acetone, chloroform, diethyl ether, benzene, ethyl acetate, and hydrocarbon solvents;   (g) an R.sub.ƒ value of approximately 0.53 on reversed-phase silica-gel TLC in water:methanol:acetonitrile (45:15:40) which contains 0.2% pyridine and 0.2% acetic acid:   (h) the following specific rotation: [α] D   25  +17.9° (c 0.7, H 2  O); or a cationic or acid addition salt of A-21978C factor C 5 .     
     
     
       17. A compound of claim 16 which is a pharmaceutically acceptable salt of A-21978C factor C 5 . 
     
     
       18. The compound of claim 16 which is A-21978C factor C 5  sodium salt.